Easy Access and Express Report Delivery Service
Synthetic Lethality-based Drugs and Targets Market, Global Outlook and Forecast 2024-2030
Report ID
49057
Publisher
Market Monitor Global
Published Date
07-Feb
Delivery Format
PDF
No of Report Page
102
Editor's Rating
-
Report Details
This research report provides a comprehensive analysis of the Synthetic Lethality-based Drugs and Targets market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Synthetic Lethality-based Drugs and Targets market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Synthetic Lethality-based Drugs and Targets, challenges faced by the industry, and potential opportunities for market players. The global Synthetic Lethality-based Drugs and Targets market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Synthetic Lethality-based Drugs and Targets market presents opportunities for various stakeholders, including Medical Research Institution, Hospital and Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Synthetic Lethality-based Drugs and Targets market. Additionally, the growing consumer demand present avenues for market expansion. The global Synthetic Lethality-based Drugs and Targets market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Key Features: The research report on the Synthetic Lethality-based Drugs and Targets market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders. Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Synthetic Lethality-based Drugs and Targets market. Market Overview: The report provides a comprehensive overview of the Synthetic Lethality-based Drugs and Targets market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Monotherapy, Combination Therapy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment. Market Dynamics: The report analyses the market dynamics driving the growth and development of the Synthetic Lethality-based Drugs and Targets market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Synthetic Lethality-based Drugs and Targets market's trajectory. Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Synthetic Lethality-based Drugs and Targets market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. Market Segmentation and Forecast: The report segment the Synthetic Lethality-based Drugs and Targets market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions. Technological Trends: The report should highlight the key technological trends shaping the Synthetic Lethality-based Drugs and Targets market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences. Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Synthetic Lethality-based Drugs and Targets market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders. Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Synthetic Lethality-based Drugs and Targets, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments. Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Synthetic Lethality-based Drugs and Targets market. Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts. Market Segmentation Synthetic Lethality-based Drugs and Targets market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value. Market segment by Type
- Monotherapy
- Combination Therapy
- Medical Research Institution
- Hospital and Clinic
- Other
- US
- Canada
- Mexico
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- Brazil
- Argentina
- Rest of South America
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
- AbbVie
- AstraZeneca
- BeiGene
- Clovis Oncology
- GlaxoSmithKline
- Pfizer
- AtlasMedx
- Chordia Therapeutics
- IDEAYA Biosciences
- Mission Therapeutics
- Repare Therapeutics
- Sierra Oncology
- SyntheX Labs
-
Table Of Content
1 Introduction to Research & Analysis Reports 1.1 Synthetic Lethality-based Drugs and Targets Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Synthetic Lethality-based Drugs and Targets Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Synthetic Lethality-based Drugs and Targets Overall Market Size 2.1 Global Synthetic Lethality-based Drugs and Targets Market Size: 2023 VS 2030 2.2 Global Synthetic Lethality-based Drugs and Targets Market Size, Prospects & Forecasts: 2019-2030 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Synthetic Lethality-based Drugs and Targets Players in Global Market 3.2 Top Global Synthetic Lethality-based Drugs and Targets Companies Ranked by Revenue 3.3 Global Synthetic Lethality-based Drugs and Targets Revenue by Companies 3.4 Top 3 and Top 5 Synthetic Lethality-based Drugs and Targets Companies in Global Market, by Revenue in 2023 3.5 Global Companies Synthetic Lethality-based Drugs and Targets Product Type 3.6 Tier 1, Tier 2 and Tier 3 Synthetic Lethality-based Drugs and Targets Players in Global Market 3.6.1 List of Global Tier 1 Synthetic Lethality-based Drugs and Targets Companies 3.6.2 List of Global Tier 2 and Tier 3 Synthetic Lethality-based Drugs and Targets Companies 4 Market Sights by Product 4.1 Overview 4.1.1 By Type - Global Synthetic Lethality-based Drugs and Targets Market Size Markets, 2023 & 2030 4.1.2 Monotherapy 4.1.3 Combination Therapy 4.2 By Type - Global Synthetic Lethality-based Drugs and Targets Revenue & Forecasts 4.2.1 By Type - Global Synthetic Lethality-based Drugs and Targets Revenue, 2019-2024 4.2.2 By Type - Global Synthetic Lethality-based Drugs and Targets Revenue, 2025-2030 4.2.3 By Type - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Synthetic Lethality-based Drugs and Targets Market Size, 2023 & 2030 5.1.2 Medical Research Institution 5.1.3 Hospital and Clinic 5.1.4 Other 5.2 By Application - Global Synthetic Lethality-based Drugs and Targets Revenue & Forecasts 5.2.1 By Application - Global Synthetic Lethality-based Drugs and Targets Revenue, 2019-2024 5.2.2 By Application - Global Synthetic Lethality-based Drugs and Targets Revenue, 2025-2030 5.2.3 By Application - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030 6 Sights by Region 6.1 By Region - Global Synthetic Lethality-based Drugs and Targets Market Size, 2023 & 2030 6.2 By Region - Global Synthetic Lethality-based Drugs and Targets Revenue & Forecasts 6.2.1 By Region - Global Synthetic Lethality-based Drugs and Targets Revenue, 2019-2024 6.2.2 By Region - Global Synthetic Lethality-based Drugs and Targets Revenue, 2025-2030 6.2.3 By Region - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030 6.3 North America 6.3.1 By Country - North America Synthetic Lethality-based Drugs and Targets Revenue, 2019-2030 6.3.2 US Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.3.3 Canada Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.3.4 Mexico Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.4 Europe 6.4.1 By Country - Europe Synthetic Lethality-based Drugs and Targets Revenue, 2019-2030 6.4.2 Germany Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.4.3 France Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.4.4 U.K. Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.4.5 Italy Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.4.6 Russia Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.4.7 Nordic Countries Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.4.8 Benelux Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.5 Asia 6.5.1 By Region - Asia Synthetic Lethality-based Drugs and Targets Revenue, 2019-2030 6.5.2 China Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.5.3 Japan Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.5.4 South Korea Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.5.5 Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.5.6 India Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.6 South America 6.6.1 By Country - South America Synthetic Lethality-based Drugs and Targets Revenue, 2019-2030 6.6.2 Brazil Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.6.3 Argentina Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.7 Middle East & Africa 6.7.1 By Country - Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue, 2019-2030 6.7.2 Turkey Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.7.3 Israel Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.7.4 Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 6.7.5 UAE Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030 7 Synthetic Lethality-based Drugs and Targets Companies Profiles 7.1 AbbVie 7.1.1 AbbVie Company Summary 7.1.2 AbbVie Business Overview 7.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Major Product Offerings 7.1.4 AbbVie Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024) 7.1.5 AbbVie Key News & Latest Developments 7.2 AstraZeneca 7.2.1 AstraZeneca Company Summary 7.2.2 AstraZeneca Business Overview 7.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Major Product Offerings 7.2.4 AstraZeneca Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024) 7.2.5 AstraZeneca Key News & Latest Developments 7.3 BeiGene 7.3.1 BeiGene Company Summary 7.3.2 BeiGene Business Overview 7.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Major Product Offerings 7.3.4 BeiGene Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024) 7.3.5 BeiGene Key News & Latest Developments 7.4 Clovis Oncology 7.4.1 Clovis Oncology Company Summary 7.4.2 Clovis Oncology Business Overview 7.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Major Product Offerings 7.4.4 Clovis Oncology Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024) 7.4.5 Clovis Oncology Key News & Latest Developments 7.5 GlaxoSmithKline 7.5.1 GlaxoSmithKline Company Summary 7.5.2 GlaxoSmithKline Business Overview 7.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Major Product Offerings 7.5.4 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024) 7.5.5 GlaxoSmithKline Key News & Latest Developments 7.6 Pfizer 7.6.1 Pfizer Company Summary 7.6.2 Pfizer Business Overview 7.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Major Product Offerings 7.6.4 Pfizer Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024) 7.6.5 Pfizer Key News & Latest Developments 7.7 AtlasMedx 7.7.1 AtlasMedx Company Summary 7.7.2 AtlasMedx Business Overview 7.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Major Product Offerings 7.7.4 AtlasMedx Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024) 7.7.5 AtlasMedx Key News & Latest Developments 7.8 Chordia Therapeutics 7.8.1 Chordia Therapeutics Company Summary 7.8.2 Chordia Therapeutics Business Overview 7.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Major Product Offerings 7.8.4 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024) 7.8.5 Chordia Therapeutics Key News & Latest Developments 7.9 IDEAYA Biosciences 7.9.1 IDEAYA Biosciences Company Summary 7.9.2 IDEAYA Biosciences Business Overview 7.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Major Product Offerings 7.9.4 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024) 7.9.5 IDEAYA Biosciences Key News & Latest Developments 7.10 Mission Therapeutics 7.10.1 Mission Therapeutics Company Summary 7.10.2 Mission Therapeutics Business Overview 7.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Major Product Offerings 7.10.4 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024) 7.10.5 Mission Therapeutics Key News & Latest Developments 7.11 Repare Therapeutics 7.11.1 Repare Therapeutics Company Summary 7.11.2 Repare Therapeutics Business Overview 7.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Major Product Offerings 7.11.4 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024) 7.11.5 Repare Therapeutics Key News & Latest Developments 7.12 Sierra Oncology 7.12.1 Sierra Oncology Company Summary 7.12.2 Sierra Oncology Business Overview 7.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Major Product Offerings 7.12.4 Sierra Oncology Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024) 7.12.5 Sierra Oncology Key News & Latest Developments 7.13 SyntheX Labs 7.13.1 SyntheX Labs Company Summary 7.13.2 SyntheX Labs Business Overview 7.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Major Product Offerings 7.13.4 SyntheX Labs Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024) 7.13.5 SyntheX Labs Key News & Latest Developments 8 Conclusion 9 Appendix 9.1 Note 9.2 Examples of Clients 9.3 Disclaimer
-
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
